PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18295112-1	2008	OBJECTIVES: The goal of this study was to evaluate the ability of recombinant human thrombomodulin (rTM) to inhibit neointimal hyperplasia when bound to expanded polytetrafluoroethylene (ePTFE) stent grafts placed in a porcine balloon injured carotid artery model.	Polytetrafluoroethylene	162-185	thrombomodulin	Homo sapiens	84-98	
12121708-0	2002	Immobilization of human thrombomodulin to expanded polytetrafluoroethylene.	Polytetrafluoroethylene	51-74	thrombomodulin	Homo sapiens	24-38	
9259510-0	1997	Microwave CO2 plasma-initiated vapour phase graft polymerization of acrylic acid onto polytetrafluoroethylene for immobilization of human thrombomodulin.	Polytetrafluoroethylene	86-109	thrombomodulin	Homo sapiens	138-152	
9259510-1	1997	The functionalization of polytetrafluoroethylene (PTFE) for human thrombomodulin (hTM) binding has been achieved by CO2 plasma activation and subsequent vapour phase graft polymerization of acrylic acid (AA).	Polytetrafluoroethylene	25-48	thrombomodulin	Homo sapiens	66-80	
9259510-1	1997	The functionalization of polytetrafluoroethylene (PTFE) for human thrombomodulin (hTM) binding has been achieved by CO2 plasma activation and subsequent vapour phase graft polymerization of acrylic acid (AA).	Polytetrafluoroethylene	50-54	thrombomodulin	Homo sapiens	66-80